Abstract

Off-pump coronary artery bypass grafting (OPCAB) avoids the deleterious systemic inflammatory effects of the extracorporeal circuit. When a patient must pay all treatment expenses, cost cutting becomes very important to the treating surgeon. Considering both factors, an Acrobat-SUV heart stabiliser was used in the first 110 OPCAB patients to keep the expenditure minimal; the results were analysed at the end of 5 years.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.